BR9909522A - Ligandos do receptor 5-ht1 azabicìclicos - Google Patents

Ligandos do receptor 5-ht1 azabicìclicos

Info

Publication number
BR9909522A
BR9909522A BR9909522-0A BR9909522A BR9909522A BR 9909522 A BR9909522 A BR 9909522A BR 9909522 A BR9909522 A BR 9909522A BR 9909522 A BR9909522 A BR 9909522A
Authority
BR
Brazil
Prior art keywords
azabicyclic
receptor ligands
compounds
useful
formula
Prior art date
Application number
BR9909522-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Gene Michael Bright
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9909522A publication Critical patent/BR9909522A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Gynecology & Obstetrics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Luminescent Compositions (AREA)
BR9909522-0A 1998-04-09 1999-03-18 Ligandos do receptor 5-ht1 azabicìclicos BR9909522A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8123798P 1998-04-09 1998-04-09
PCT/IB1999/000457 WO1999052907A1 (en) 1998-04-09 1999-03-18 Azabicyclic 5ht1 receptor ligands

Publications (1)

Publication Number Publication Date
BR9909522A true BR9909522A (pt) 2000-12-19

Family

ID=22162936

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909522-0A BR9909522A (pt) 1998-04-09 1999-03-18 Ligandos do receptor 5-ht1 azabicìclicos

Country Status (41)

Country Link
US (2) US6525048B1 (hu)
EP (1) EP1070065B1 (hu)
JP (1) JP3496759B2 (hu)
KR (1) KR100378931B1 (hu)
CN (1) CN1117092C (hu)
AP (1) AP1175A (hu)
AR (1) AR015751A1 (hu)
AT (1) ATE248838T1 (hu)
AU (1) AU749254B2 (hu)
BG (1) BG104915A (hu)
BR (1) BR9909522A (hu)
CA (1) CA2327782A1 (hu)
CO (1) CO5080727A1 (hu)
CZ (1) CZ20003684A3 (hu)
DE (1) DE69910997T2 (hu)
DK (1) DK1070065T3 (hu)
DZ (1) DZ2756A1 (hu)
EA (1) EA003400B1 (hu)
ES (1) ES2204154T3 (hu)
HK (1) HK1035719A1 (hu)
HR (1) HRP20000653A2 (hu)
HU (1) HUP0102400A3 (hu)
ID (1) ID26086A (hu)
IL (1) IL138629A0 (hu)
IS (1) IS5641A (hu)
MA (1) MA26619A1 (hu)
MY (1) MY133390A (hu)
NO (1) NO20005004L (hu)
NZ (1) NZ507010A (hu)
OA (1) OA11496A (hu)
PA (1) PA8469101A1 (hu)
PE (1) PE20000413A1 (hu)
PL (1) PL343408A1 (hu)
PT (1) PT1070065E (hu)
SK (1) SK14782000A3 (hu)
TN (1) TNSN99056A1 (hu)
TR (1) TR200002932T2 (hu)
TW (1) TW555758B (hu)
WO (1) WO1999052907A1 (hu)
YU (1) YU59400A (hu)
ZA (1) ZA992596B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
UA62015C2 (en) 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
EP1889614A3 (en) 1999-09-03 2010-09-22 APBI Holdings, LLC Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
GB2362826A (en) * 2000-06-02 2001-12-05 Lilly Co Eli A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
ATE409475T1 (de) * 2001-02-20 2008-10-15 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
MXPA05009660A (es) * 2003-03-12 2005-10-20 Pfizer Prod Inc Derivados azabiciclicos de piridiloximetilo y bencisoxazol.
WO2005082370A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders
JP4559749B2 (ja) * 2004-02-16 2010-10-13 あすか製薬株式会社 ピペラジニルピリジン誘導体
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
AR048112A1 (es) 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
CA2571555A1 (en) * 2004-06-22 2006-01-05 Pfizer Products Inc. Diazabicyclic histamine-3 receptor antagonists
EP2400300A1 (en) 2004-08-25 2011-12-28 Takeda Pharmaceutical Company Limited Method of screening preventives/remedies for stress urinary incontinence
BRPI0514793A (pt) * 2004-09-10 2008-06-24 Pfizer Prod Inc uso de derivados azabicìclicos de benzisoxazol e piridiloximetila na preparação de um medicamento para o tratamento de distúrbios cognitivos
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106849A (en) * 1988-05-24 1992-04-21 American Home Products Corporation Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
ES2096099T3 (es) * 1991-09-25 1997-03-01 Pfizer Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
US5262428A (en) * 1992-03-13 1993-11-16 Wake Forest University Biologically active tropane derivatives
DK0646116T3 (da) * 1992-06-16 1999-12-27 Pfizer Fremgangsmåde og mellemprodukter til fremstilling af bis-aza-bicycliske anxiolytiske midler
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
KR100378931B1 (ko) 2003-04-07
AU3268799A (en) 1999-11-01
SK14782000A3 (sk) 2002-06-04
JP2002511469A (ja) 2002-04-16
US6887905B2 (en) 2005-05-03
DZ2756A1 (fr) 2003-09-15
CN1117092C (zh) 2003-08-06
NO20005004L (no) 2000-11-27
ATE248838T1 (de) 2003-09-15
AP9901502A0 (en) 1999-06-30
PA8469101A1 (es) 2000-09-29
OA11496A (en) 2004-05-14
AR015751A1 (es) 2001-05-16
CO5080727A1 (es) 2001-09-25
PL343408A1 (en) 2001-08-13
TNSN99056A1 (fr) 2005-11-10
CN1305477A (zh) 2001-07-25
AP1175A (en) 2003-06-04
DE69910997D1 (de) 2003-10-09
US20030181458A1 (en) 2003-09-25
DE69910997T2 (de) 2004-05-19
MY133390A (en) 2007-11-30
ID26086A (id) 2000-11-23
IL138629A0 (en) 2001-10-31
CZ20003684A3 (cs) 2002-03-13
EP1070065A1 (en) 2001-01-24
IS5641A (is) 2000-09-26
MA26619A1 (fr) 2004-12-20
ES2204154T3 (es) 2004-04-16
HRP20000653A2 (en) 2001-04-30
HK1035719A1 (en) 2001-12-07
KR20010042527A (ko) 2001-05-25
HUP0102400A3 (en) 2002-10-28
PT1070065E (pt) 2003-12-31
CA2327782A1 (en) 1999-10-21
JP3496759B2 (ja) 2004-02-16
NZ507010A (en) 2003-05-30
WO1999052907A1 (en) 1999-10-21
EA003400B1 (ru) 2003-04-24
TW555758B (en) 2003-10-01
DK1070065T3 (da) 2003-11-24
US6525048B1 (en) 2003-02-25
YU59400A (sh) 2003-10-31
AU749254B2 (en) 2002-06-20
EA200000910A1 (ru) 2001-04-23
TR200002932T2 (tr) 2001-01-22
PE20000413A1 (es) 2000-05-25
EP1070065B1 (en) 2003-09-03
HUP0102400A2 (hu) 2001-11-28
BG104915A (en) 2001-07-31
NO20005004D0 (no) 2000-10-04
ZA992596B (en) 2000-10-08

Similar Documents

Publication Publication Date Title
BR9909522A (pt) Ligandos do receptor 5-ht1 azabicìclicos
HK1047098A1 (en) Tri-aryl acid derivatives as ppar receptor ligands.
BR9904372A (pt) Sulfanil-silanos
PL337329A1 (en) Oxazolydinone based antibacterial agents comprising a thiocarbonyl functional group
MXPA02012271A (es) Nuevos compuestos que poseen actividad antibacteriana, antifungal o antitumor.
BR0010215A (pt) Derivados de indolina como antagonistas de progesterona
UY27026A1 (es) Derivados benzodiacepínicos como moduladores de los receptores gaba a
ES2188666T3 (es) Analogos de la distamicina utilies como agentes antitumorales o antivirales.
BR0115436A (pt) Compostos de piperazinilpirazina atuando como antagonistas do receptor 5ht-2 de serotonina
BG106340A (en) Substituted oxoazaheterocyclyl compounds
BR9804214A (pt) Compostos.
CY1108567T1 (el) Αντιθρομβωτικες ενωσεις
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
BR9806852A (pt) Antagonistas receptores de vitronectina
PL344475A1 (en) Bridged indenopyrrolocarbazoles
SE9702773D0 (sv) Novel compounds
BR9916680A (pt) Derivados da 3,3-biarilpiperidina e2,2-biarilmorfolina
MXPA01008347A (es) Compuestos quimicos.
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
SE9801494D0 (sv) Novel use
UA66866C2 (uk) Синтез морфолінових похідних
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
IT1314278B1 (it) Composti costituiti da ammine che presentano impedimenti sterici.
SE9904128D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements